RenovoRx, Inc.
RNXT
$1.35
$0.043.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.42M | -2.88M | -2.47M | -2.39M | -1.08M |
| Total Depreciation and Amortization | 1.00K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -274.00K | 590.00K | 22.00K | -264.00K | -939.00K |
| Change in Net Operating Assets | -688.00K | -142.00K | 255.00K | 356.00K | -189.00K |
| Cash from Operations | -3.38M | -2.43M | -2.19M | -2.30M | -2.20M |
| Capital Expenditure | -2.00K | -12.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.00K | -12.00K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.81M | 33.00K | 15.00K | 9.65M | 5.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.81M | 33.00K | 15.00K | 9.65M | 5.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.43M | -2.41M | -2.18M | 7.35M | 3.22M |